We are excited to announce that Xcellerate® Medical Review has been named a finalist in the Clinical & Research Excellence (CARE) Awards. As a finalist in the Best Sponsor-Focused Technological Development category, Xcellerate Medical Review is being recognized for its modern approach to improving the clinical trial process. The CARE Awards recognize excellence across the global clinical research enterprise.
The Xcellerate Medical Review informatics product provides a critical function to study sponsors to safeguard subject safety, increase the robustness and quality of clinical trial execution, improve the reliability of investigational data and ensure adherence to ethical standards. Xcellerate Medical Review is a part of the larger award-winning Xcellerate Clinical Trial Optimization® suite, a comprehensive informatics solution that can meaningfully reduce the cost, time, complexity and risk of drug development.
This finalist status is the latest recognition the Xcellerate suite has earned in recent months. Dimitris Agrafiotis, chief data officer and head of technology products, was named a 2017 Premier 100 Technology Leader by IDG Computerworld for his work transforming the drug development process. Additionally, Fierce Innovation recognized Xcellerate Trial Design as “Best Outsourcing Partner” in the 2016 Fierce Innovation Awards, which showcase outstanding advancements in the pharmaceutical industry. This is the second nomination for us in the CARE Awards. In 2016, Xcellerate Monitoring, a solution in the Xcellerate Informatics Suite, was named the Best Sponsor-Focused Technological Development.
“The insights into patient safety and operational efficiency delivered by informatics are vital to improving trial outcomes,” said Andrew Chapman, senior product director for informatics. “It is exciting that with our Xcellerate product we can make significant contributions to enhancing the clinical trial process.”
We look forward to continuing this record of success. We are driven by a passion for excellence and a commitment to quality. “We never stop innovating,” Chapman continued. “We are relentlessly focused on delivering the best products that solve some of the industry’s toughest problems.”